Curebound

Curebound is headquartered in San Diego amidst a unique combination of three NCI-cancer centers, clinical care hospitals, biotech companies, venture capital investors, philanthropic networks, and most importantly- a regional culture that embraces the spirit of collaboration.

This ecosystem positions San Diego and Curebound at the forefront of discovery - bringing genomic medicine, new technologies and clinical trials to market and presents an unprecedented opportunity for research collaboration. We believe that the next decade will be critical to the development of sophisticated, personalized approaches in the way we prevent, treat and ultimately find cures for cancer.

Curebound is committed to investing $100 million into collaborative cancer research in San Diego to make the vision of cures in our lifetime a reality.